about
Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other DiseasesCommunication over the network of binary switches regulates the activation of A2A adenosine receptorMolecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTsBalancing focused combinatorial libraries based on multiple GPCR ligands.Discovery of New Human A(2A) Adenosine Receptor Agonists: Design, Synthesis, and Binding Mode of Truncated 2-Hexynyl-4'-thioadenosine.Total synthesis of the putative structure of the proposed Banyasin A.Receptor activity and conformational analysis of 5'-halogenated resiniferatoxin analogs as TRPV1 ligands2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-regionIdentification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug developmentN-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism.Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014).5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression.Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.Role of computer-aided drug design in modern drug discovery.The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.Design, synthesis, and anticancer activity of C8-substituted-4'-thionucleosides as potential HSP90 inhibitors.Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications.Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling.Expediting the Design, Discovery, and Development of Anticancer Drugs using Computational Approaches.Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation.Ultraslow Water-Mediated Transmembrane Interactions Regulate the Activation of A2A Adenosine Receptor.6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists.In silico classification of adenosine receptor antagonists using Laplacian-modified naïve Bayesian, support vector machine, and recursive partitioning.Link between allosteric signal transduction and functional dynamics in a multisubunit enzyme: S-adenosylhomocysteine hydrolase.2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region.In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method.MLACP: machine-learning-based prediction of anticancer peptides.Mapping the intramolecular signal transduction of G-protein coupled receptors.Inhibitory effect of tartrate against phosphate-induced DJ-1 aggregation.Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity.Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands.Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.N6-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation.
P50
Q26741831-BCCF71D2-B9FE-439B-BA3C-E4B325A460F8Q27320028-E5A5109C-FB6B-4783-9211-F532FD9304CEQ28487027-7FD17052-5ABF-400E-87BC-6AB02FC232A7Q33260987-917563B7-2559-4057-A0DF-235867060DABQ34536571-A5192A91-91B6-49E9-9D13-71497CDE6734Q35184132-355ECA15-FA63-432B-9ACC-F9084B74DA42Q36168257-0737A2BE-B915-4443-9B3C-EDC5052B65A1Q36312945-7772AA91-682E-4CCF-98AF-540C512B4538Q36643383-62272619-5CF1-4D3C-AD34-6735C91FF3EEQ37059435-406BC266-E0E9-4905-B8A2-DFF24675E95DQ37237752-42CAFE28-F18A-4553-87C7-8A3633E5D9AFQ37637798-CD29533A-4D2A-495D-B59B-41E4D1ADD72AQ38349917-A9E66766-F076-4E2A-9D65-A68798A31E8FQ38421800-3F7C4217-5092-4C31-889B-6C34B9569A81Q38425711-F201C150-6C32-4350-83E3-0A2FA6EF3BF2Q38553677-A2744F8B-55E1-484A-9129-65893788192FQ38750484-00A63F99-CBC4-4C24-9759-BD811685B0C7Q38758456-CB18D3A8-8711-4524-A217-8B963BC27C86Q38765375-7423F00A-F990-4DE7-9E78-95768412F195Q38796329-BF3C99C6-DE82-4698-A984-E2989410FC7BQ38895275-A40B8BE1-02DE-47AE-840E-274AE12CDFABQ38946205-A06BC2F1-BC75-41D7-AFAF-16D3410B587FQ39747666-93A38F46-6101-4DDF-A46B-972B4412356EQ41012941-756D6BE1-3C84-4C13-8220-09DDF3DA0687Q41165117-7EF8186C-B23C-4C58-9A87-849A0447E947Q41569734-55D43142-9771-4C17-9607-53E688006C65Q43071611-2D73FE57-33EF-495C-BBC3-63A5EC33C848Q44167420-530196ED-20D4-4ACC-9E54-68177E9D065EQ44934265-EF15E452-D4D4-43D8-9A25-F996776804E6Q45943509-921F335C-4E64-4B22-A2A4-CB6ED9504C57Q45944202-FBCDA52E-EF4F-41D1-94D6-9B762246C969Q46127492-67B432AB-E7A9-4342-B9BE-72447F8CB809Q46286296-AF1D68A5-5910-4AB7-AA1A-3A83316221BFQ46825460-96F5C271-944F-4118-A924-EF134CA5A171Q46962538-78294CE7-987A-4DA5-A23F-08FB453FA2E9Q47688767-0002A496-1C16-4DD3-9FC1-87F8FBB59D9DQ47909432-6116E5C5-92E8-4E65-AA99-B0F87C62AE7AQ48197891-75222459-F84D-43D9-91F8-B404E43990A7Q48209337-B8F529CC-E701-4FFD-B3A0-1DDAB2D048E9Q48316436-DA9B5902-A092-4616-B4CB-8F5DF0503F31
P50
description
Investigador(a)
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sun Choi
@ast
Sun Choi
@en
Sun Choi
@es
Sun Choi
@nl
Sun Choi
@sl
type
label
Sun Choi
@ast
Sun Choi
@en
Sun Choi
@es
Sun Choi
@nl
Sun Choi
@sl
prefLabel
Sun Choi
@ast
Sun Choi
@en
Sun Choi
@es
Sun Choi
@nl
Sun Choi
@sl
P106
P1153
8659831000
P31
P496
0000-0002-7669-7954
P569
2000-01-01T00:00:00Z